nodes	percent_of_prediction	percent_of_DWPC	metapath
Phensuximide—Phenmetrazine—SLC6A3—Gilles de la Tourette syndrome	0.355	0.547	CrCbGaD
Phensuximide—Phendimetrazine—SLC6A3—Gilles de la Tourette syndrome	0.294	0.453	CrCbGaD
Phensuximide—CACNA1I—brain—Gilles de la Tourette syndrome	0.0784	0.223	CbGeAlD
Phensuximide—CACNA1G—nervous system—Gilles de la Tourette syndrome	0.0703	0.2	CbGeAlD
Phensuximide—CACNA1G—central nervous system—Gilles de la Tourette syndrome	0.0677	0.193	CbGeAlD
Phensuximide—CACNA1G—brain—Gilles de la Tourette syndrome	0.0537	0.153	CbGeAlD
Phensuximide—CACNA1H—nervous system—Gilles de la Tourette syndrome	0.046	0.131	CbGeAlD
Phensuximide—CACNA1H—brain—Gilles de la Tourette syndrome	0.0351	0.1	CbGeAlD
